Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial

BACKGROUND: Randomized controlled trials have shown that treatment of chronically ventilated preterm infants after the first week of life with dexamethasone reduces the incidence of the combined outcome death or bronchopulmonary dysplasia (BPD). However, there are concerns that dexamethasone may inc...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Onland, Wes, Offringa, Martin, Cools, Filip, De Jaegere, Anne P, Rademaker, Karin, Blom, Henry, Cavatorta, Eric, Debeer, Anne, Dijk, Peter H, van Heijst, Arno F, Kramer, Boris W, Kroon, Andre A, Mohns, Thilo, van Straaten, Henrica L, te Pas, Arjan B, Theyskens, Claire, van Weissenbruch, Mirjam M, van Kaam, Anton H
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2011
נושאים:
Study Protocol
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3245429/
https://ncbi.nlm.nih.gov/pubmed/22070744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2431-11-102
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים